NCT00424398

Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis

A Single-Center, Double-Masked, Randomized, Placebo-Controlled, Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 107 (actual)
• Sponsor: Bausch & Lomb Incorporated · Industry
• Sex: All
• Age: 10 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate whether bepotastine besilate ophthalmic solution is effective in the treatment of acute allergic conjunctivitis

Conditions

• Conjunctivitis, Allergic

Interventions

Type	Name	Description
DRUG	Bepreve	sterile ophthalmic solution
DRUG	Placebo	sterile ophthalmic solution
DRUG	Bepotastine Besilate	sterile ophthalmic solution

Timeline

• Start date: 2007-02-01
• Primary completion: 2007-07-01
• First posted: 2007-01-19
• Last updated: 2013-02-15
• Results posted: 2012-03-26

Locations

1 site across 1 country: United States